-
All we need to know about COVID-19 10
-
What are the differences between the first wave and second wave in India?Lecture1.1
-
How to assess risk Factors for Severe DiseaseLecture1.2
-
How to manage on Day 1 of symptoms with COVID-19?Lecture1.3
-
How to Interpret the Lab Findings in Mild/Moderate/Severe cases:Lecture1.4
-
How to manage patients with information from the lab tests?Lecture1.5
-
When to access need for critical care intervention?Lecture1.6
-
What Investigations may be needed for inpatients?Lecture1.7
-
HRCT in Covid – Indications and importance of HRCT Thorax:Lecture1.8
-
Summary Points in COVID-19 Management.Lecture1.9
-
Do’s and Don’ts in Covid 19:Lecture1.10
-
-
CONCLUSION: 0
The COVID-19 infection has two phases, the first is the viraemic phase and the second one is the immunologic phase. These two have to be promptly identified and managed appropriately as mentioned above. The critical treatments are oxygen therapy when hypoxic and steroids during severe immunologic phase of the disease. Non Invasive Ventilation and other supportive care including appropriate anticoagulation when needed are crucial and may help to avoid ventilation as prognosis by then can be grim with almost 30-50% mortality.
No items in this section
How to assess risk Factors for Severe Disease
- Age > 60 years.
- CVA or CAD (MI, PCI, or CABG) within previous 6 months
- Heart Failure (NYHA Class 3 and 4).
- Chronic Respiratory Disease e.g., COPD, Bronchial Asthma, ILD, etc.
- Uncontrolled Diabetes Mellitus (HbA1C ≥9% or random glucose >300 mg/dl).
- Systemic hypertension with systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg.
- Active cancer.
- Chronic kidney disease.
- Decompensated chronic liver disease (Presence of edema, jaundice, ascites)
- Transplantations
- On immunosuppressive treatment currently.
- Morbid obesity (BMI ≥40).